title: Advances in targeted therapy for osteosarcoma.
abstract: Osteosarcoma is an aggressive cancer in skeletal system with unknown molecular mechanisms of etiology and pathogenesis, therefore it remains a challenge for current therapeutic strategies to effectively treat osteosarcoma. The aim of this review is to give an overview of the molecular and mechanistic changes identified in recent years which might be new targets for the treatment of osteosarcoma. These molecules play important roles in different biological and pathological programs of osteosarcoma, including the altered oncogenes and tumor suppressor genes, molecules involved in tumor cell migration and invasion, angiogenesis, apoptosis and proliferation, miRNAs, and molecules involved in osteoclast function and multidrug resistance. Further research on these molecules in osteosarcoma will provide new insights into the target therapy for osteosarcoma.
authors: Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Hospital and Institute, Tianjin 300060, China and National Clinical Research Center for Cancer, Tianjin Medical University Cancer Hospital and Institute, Tianjin 300060, China.
authors: Wenya
authors: W
authors: Zhou
authors: Mengze
authors: M
authors: Hao
authors: Xiaoling
authors: X
authors: Du
authors: Kexin
authors: K
authors: Chen
authors: Guowen
authors: G
authors: Wang
authors: Jilong
authors: J
authors: Yang
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D019008:Drug Resistance, Neoplasm; D006801:Humans; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism; D058990:Molecular Targeted Therapy; D010010:Osteoclasts / Q000378:metabolism / Q000473:pathology; D012516:Osteosarcoma / Q000098:blood supply / Q000235:genetics / Q000473:pathology / Q000628:therapy*
chemical_list: D035683:MicroRNAs